| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $3,516,888 ) |
| | 2024 | 2024 | SWEDISH HEALTH SERVICES | 747 BROADWAY | SEATTLE | WA | 98122-4379 | KING | USA | UG1CA189953 | The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site | 001 | 11 | NIH | 7/16/2024 | $2,632,282 |
| | 2024 | 2024 | SWEDISH HEALTH SERVICES | 747 BROADWAY | SEATTLE | WA | 98122-4379 | KING | USA | R21CA267394 | Using proteogenomics to assess the functional impact of alternative splicing events in glioblastoma | 000 | 2 | NIH | 11/22/2023 | $207,100 |
| | 2024 | 2024 | SWEDISH HEALTH SERVICES | 747 Broadway | Seattle | WA | 98122-4307 | KING | USA | T2537615 | Addiction Medicine Fellowship | 00 | 5 | HRSA | 5/16/2024 | $641,390 |
| | 2024 | 2024 | SWEDISH HEALTH SERVICES | 747 Broadway | Seattle | WA | 98122-4307 | KING | USA | T2537615 | Addiction Medicine Fellowship | 01 | 5 | HRSA | 7/23/2024 | $24,612 |
| | 2024 | 2024 | SWEDISH HEALTH SERVICES | 747 BROADWAY | SEATTLE | WA | 98122-4379 | KING | USA | R21CA267394 | Using proteogenomics to assess the functional impact of alternative splicing events in glioblastoma | 001 | 2 | NIH | 4/24/2024 | $11,504 |
| | 2024 | 2023 | SWEDISH HEALTH SERVICES | 747 BROADWAY | SEATTLE | WA | 98122-4379 | KING | USA | UG1CA189953 | The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site | 000 | 10 | NIH | 5/29/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $3,243,212 ) |
| | 2023 | 2023 | SWEDISH HEALTH SERVICES | 747 BROADWAY | SEATTLE | WA | 98122-4379 | KING | USA | UG1CA189953 | The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site | 001 | 10 | NIH | 7/28/2023 | $2,544,202 |
| | 2023 | 2023 | SWEDISH HEALTH SERVICES | 747 Broadway | Seattle | WA | 98122-4307 | KING | USA | T2537615 | Addiction Medicine Fellowship | 01 | 4 | HRSA | 9/15/2023 | $37,104 |
| | 2023 | 2023 | SWEDISH HEALTH SERVICES | 747 Broadway | Seattle | WA | 98122-4379 | KING | USA | T2537615 | Addiction Medicine Fellowship | 00 | 4 | HRSA | 5/8/2023 | $613,158 |
| | 2023 | 2023 | SWEDISH HEALTH SERVICES | 747 BROADWAY | SEATTLE | WA | 98122-4379 | KING | USA | R21CA267394 | Using proteogenomics to assess the functional impact of alternative splicing events in glioblastoma | 000 | 1 | NIH | 12/21/2022 | $207,023 |
| | 2023 | 2022 | SWEDISH HEALTH SERVICES | 747 BROADWAY | SEATTLE | WA | 98122-4379 | KING | USA | UG1CA189953 | The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site | 000 | 9 | NIH | 5/23/2023 | $0 |
| | 2023 | 2018 | SWEDISH HEALTH SERVICES | 747 BROADWAY | SEATTLE | WA | 98122-4379 | KING | USA | R01MH109319 | Unobtrusive Sensing of Medication Intake ("USE-MI") | 000 | 4 | NIH | 7/19/2023 | -$5,770 |
| | 2023 | 2018 | SWEDISH HEALTH SERVICES | 747 BROADWAY | SEATTLE | WA | 98122-4379 | KING | USA | R01MH109319 | Unobtrusive Sensing of Medication Intake ("USE-MI") | 000 | 4 | NIH | 7/19/2023 | -$152,505 |
|
| Issue Date FY: 2022 ( Subtotal = $3,179,796 ) |
| | 2022 | 2022 | SWEDISH HEALTH SERVICES | 747 BROADWAY | SEATTLE | WA | 98122-4379 | KING | USA | UG1CA189953 | The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site | 000 | 9 | NIH | 8/8/2022 | $2,579,213 |
| | 2022 | 2022 | Swedish Health Services | 747 Broadway | Seattle | WA | 98122-4379 | KING | USA | T2537615 | Addiction Medicine Fellowship | 00 | 3 | HRSA | 5/10/2022 | $600,583 |
| | 2022 | 2022 | Swedish Health Services | 747 Broadway | Seattle | WA | 98122-4379 | KING | USA | T2537615 | Addiction Medicine Fellowship | 01 | 3 | HRSA | 7/12/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $3,020,155 ) |
| | 2021 | 2021 | Swedish Health Services | 747 Broadway | Seattle | WA | 98122-4379 | KING | USA | T2537615 | Addiction Medicine Fellowship | 00 | 2 | HRSA | 5/26/2021 | $571,753 |
| | 2021 | 2021 | SWEDISH HEALTH SERVICES | 747 BROADWAY | SEATTLE | WA | 98122-4379 | KING | USA | UG1CA189953 | The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site | 000 | 8 | NIH | 8/1/2021 | $2,878,421 |
| | 2021 | 2018 | SWEDISH HEALTH SERVICES | 747 BROADWAY | SEATTLE | WA | 98122-4379 | KING | USA | R21AR072930 | Osteoporosis Treatment and Drug Holiday Duration | 000 | 2 | NIH | 2/4/2021 | $0 |
| | 2021 | 2018 | SWEDISH HEALTH SERVICES | 747 BROADWAY | SEATTLE | WA | 98122-4379 | KING | USA | R01MH109319 | Unobtrusive Sensing of Medication Intake ("USE-MI") | 000 | 4 | NIH | 6/24/2021 | $0 |
| | 2021 | 2018 | SWEDISH HEALTH SERVICES | 747 BROADWAY | SEATTLE | WA | 98122-4379 | KING | USA | R01MH109319 | Unobtrusive Sensing of Medication Intake ("USE-MI") | 000 | 4 | NIH | 6/24/2021 | $0 |
| | 2021 | 2017 | SWEDISH HEALTH SERVICES | 747 BROADWAY | SEATTLE | WA | 98122-4379 | KING | USA | U10NS077309 | Swedish Neuroscience Institute / NEXT Consortium | 001 | 7 | NIH | 2/6/2021 | -$318,400 |
| | 2021 | 2017 | SWEDISH HEALTH SERVICES | 747 BROADWAY | SEATTLE | WA | 98122-4379 | KING | USA | R01CA184283 | The Role of Cidofovir and Structural Analogs as Adjuvant Therapy for Glioblastoma | 000 | 4 | NIH | 3/11/2021 | -$35,693 |
| | 2021 | 2016 | SWEDISH HEALTH SERVICES | 747 BROADWAY | SEATTLE | WA | 98122-4379 | KING | USA | U10NS077309 | Swedish Neuroscience Institute / NEXT Consortium | 000 | 6 | NIH | 2/6/2021 | -$75,925 |
|
| Issue Date FY: 2020 ( Subtotal = $2,535,949 ) |
| | 2020 | 2020 | SWEDISH HEALTH SERVICES | 747 BROADWAY | SEATTLE | WA | 98122-4379 | KING | USA | UG1CA189953 | The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site | 003 | 7 | NIH | 7/31/2020 | $2,443,725 |
| | 2020 | 2020 | Swedish Health Services | 747 Broadway | Seattle | WA | 98122-4379 | KING | USA | T2537615 | Addiction Medicine Fellowship | 00 | 1 | HRSA | 5/28/2020 | $354,936 |
| | 2020 | 2020 | SWEDISH HEALTH SERVICES | 747 BROADWAY | SEATTLE | WA | 98122-4379 | KING | USA | UG1CA189953 | The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site | 004 | 7 | NIH | 9/10/2020 | $0 |
| | 2020 | 2019 | SWEDISH HEALTH SERVICES | 747 BROADWAY | SEATTLE | WA | 98122-4379 | KING | USA | U01DK061728 | Clinical Research Network in Nonalcoholic Steatohepatitis | 004 | 20 | NIH | 9/4/2020 | $48,594 |
| | 2020 | 2019 | SWEDISH HEALTH SERVICES | 747 BROADWAY | SEATTLE | WA | 98122-4379 | KING | USA | U01DK061728 | Clinical Research Network in Nonalcoholic Steatohepatitis | 001 | 20 | NIH | 8/20/2020 | $0 |
| | 2020 | 2019 | SWEDISH HEALTH SERVICES | 747 BROADWAY | SEATTLE | WA | 98122-4379 | KING | USA | UG1CA189953 | The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site | 002 | 6 | NIH | 4/8/2020 | $0 |
| | 2020 | 2019 | SWEDISH HEALTH SERVICES | 747 BROADWAY | SEATTLE | WA | 98122-4379 | KING | USA | UG1CA189953 | The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site | 000 | 6 | NIH | 11/26/2019 | $0 |
| | 2020 | 2019 | SWEDISH HEALTH SERVICES | 747 BROADWAY | SEATTLE | WA | 98122-4379 | KING | USA | U01DK061728 | Clinical Research Network in Nonalcoholic Steatohepatitis | 005 | 20 | NIH | 9/8/2020 | -$262,712 |
| | 2020 | 2018 | SWEDISH HEALTH SERVICES | 747 BROADWAY | SEATTLE | WA | 98122-4379 | KING | USA | UG1CA189953 | The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site | 001 | 5 | NIH | 4/8/2020 | $0 |
| | 2020 | 2018 | SWEDISH HEALTH SERVICES | 747 BROADWAY | SEATTLE | WA | 98122-4379 | KING | USA | R01MH109319 | Unobtrusive Sensing of Medication Intake ("USE-MI") | 000 | 4 | NIH | 6/30/2020 | $0 |
| | 2020 | 2018 | SWEDISH HEALTH SERVICES | 747 BROADWAY | SEATTLE | WA | 98122-4379 | KING | USA | R01MH109319 | Unobtrusive Sensing of Medication Intake ("USE-MI") | 000 | 4 | NIH | 6/30/2020 | $0 |
| | 2020 | 2018 | SWEDISH HEALTH SERVICES | 747 BROADWAY | SEATTLE | WA | 98122-4379 | KING | USA | U01DK061728 | Clinical Research Network in Nonalcoholic Steatohepatitis | 000 | 19 | NIH | 2/13/2020 | -$48,594 |
|
| Issue Date FY: 2019 ( Subtotal = $2,604,938 ) (Continued on the next page) |
| | 2019 | 2019 | SWEDISH HEALTH SERVICES | 747 BROADWAY | SEATTLE | WA | 98122-4379 | KING | USA | U01DK061728 | Clinical Research Network in Nonalcoholic Steatohepatitis | 001 | 20 | NIH | 9/11/2019 | $353,363 |
| | 2019 | 2019 | SWEDISH HEALTH SERVICES | 747 BROADWAY | SEATTLE | WA | 98122-4379 | KING | USA | UG1CA189953 | The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site | 004 | 6 | NIH | 8/23/2019 | $549,999 |
| | 2019 | 2019 | SWEDISH HEALTH SERVICES | 747 BROADWAY | SEATTLE | WA | 98122-4379 | KING | USA | UG1CA189953 | The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site | 003 | 6 | NIH | 8/16/2019 | -$1,703,976 |
| | 2019 | 2019 | SWEDISH HEALTH SERVICES | 747 BROADWAY | SEATTLE | WA | 98122-4379 | KING | USA | UG1CA189953 | The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site | 003 | 6 | NIH | 8/16/2019 | $1,703,976 |
| | 2019 | 2019 | SWEDISH HEALTH SERVICES | 747 BROADWAY | SEATTLE | WA | 98122-4379 | KING | USA | UG1CA189953 | The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site | 002 | 6 | NIH | 8/9/2019 | $1,703,976 |
| | 2019 | 2018 | SWEDISH HEALTH SERVICES | 747 BROADWAY | SEATTLE | WA | 98122-4379 | KING | USA | U01DK061728 | Clinical Research Network in Nonalcoholic Steatohepatitis | 000 | 19 | NIH | 9/6/2019 | $0 |
| | 2019 | 2018 | SWEDISH HEALTH SERVICES | 747 BROADWAY | SEATTLE | WA | 98122-4379 | KING | USA | UG1CA189953 | The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site | 001 | 5 | NIH | 2/11/2019 | $0 |
| | 2019 | 2018 | SWEDISH HEALTH SERVICES | 747 BROADWAY | SEATTLE | WA | 98122-4379 | KING | USA | UG1CA189953 | The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site | 000 | 5 | NIH | 2/4/2019 | $0 |
|
